Linde India
- Market Cap
- ₹56,049 Cr
- P/E
- 113.29
Key Fundamentals
MidcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 18.20%
- Debt to Equity
- 0.24
- EPS (TTM)
- ₹58.01
- Book Value
- ₹509.36
- Market Cap
- ₹56,049 Cr
- P/E (TTM)
- 113.29
- P/B
- 12.90
- ROE
- 13.80%
- Dividend Yield
- 0.18%
- EBITDA
- ₹927 Cr
- 52W High
- ₹8,049.00
- 52W Low
- ₹5,544.00
- Day Range
- ₹6,540.00 – ₹6,740.00
- Volume
- 19,221
Peer Comparison
Commodities › Chemicals & Petrochemicals › Industrial Gases
| 6,572.00 | 113.29 | 56,049 | 12.90 | 0.17% | 13.80% | 18.20% | 2,733 | 495 | |
| 160.91 | — | 4,448 | 7.71 | — | 25.30% | 16.00% | — | — | |
| 270.75 | 31.93 | 3,816 | 3.91 | 0.00% | 13.40% | 14.50% | 382 | 120 | |
| 181.71 | 46.12 | 2,109 | 2.97 | 0.00% | 8.93% | 11.80% | 472 | 43 | |
| 36.87 | — | 49 | 2.21 | 0.00% | 0.76% | 0.79% | 13 | −1 | |
| 56.87 | — | 29 | — | 0.00% | — | −21.50% | 14 | −7 | |
| Median 6 companies | 171.31 | 46.12 | 2,963 | 3.91 | 0.00% | 13.40% | 13.15% | 382 | 43 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 58
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 16
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 50
- Average
- Sales & profit trajectory 9% weight
- Financial Health
- 85
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 39
- Weak
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 21.8%
Weaknesses
4- Stock is trading at 12.9 times its book value
- The company has delivered a poor sales growth of 11.5% over past five years.
- Company has a low return on equity of 13.0% over last 3 years.
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 4 | 6 | 9 |
| Oscillators | Bullish | 0 | 6 | 3 |
| Moving Averages | Strong Bullish | 4 | 0 | 6 |
Oscillators
Bullish
Overall
Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 54.78
- Neutral
- MACD (12,26,9)
- 197.83
- Bullish
- SMA (50)
- 6,220.77
- Bullish
- SMA (200)
- 6,765.76
- Bearish
As of
Analyst Rating
1 of 2 analysts rate Buy, 1 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | +1.85% |
| TTM | +13.22% |
Net profit
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | +22.99% |
| TTM | −2.17% |
Operating cash flow
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | +34.59% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | +5.13 pp |
| TTM | −4.92 pp |
Revenue by year
| Dec 2015 | ₹1,567 Cr |
|---|---|
| Dec 2016 | ₹1,825 Cr |
| Dec 2017 | ₹2,033 Cr |
| Dec 2018 | ₹2,192 Cr |
| Dec 2019 | ₹1,762 Cr |
| Dec 2020 | ₹1,471 Cr |
| Dec 2021 | ₹2,112 Cr |
| Mar 2024 | ₹2,769 Cr |
| Mar 2025 | ₹2,485 Cr |
| Mar 2026 | ₹2,531 Cr |
Net profit by year
| Dec 2015 | ₹23.00 Cr |
|---|---|
| Dec 2016 | ₹13.00 Cr |
| Dec 2017 | ₹19.00 Cr |
| Dec 2018 | ₹33.00 Cr |
| Dec 2019 | ₹727 Cr |
| Dec 2020 | ₹156 Cr |
| Dec 2021 | ₹514 Cr |
| Mar 2024 | ₹426 Cr |
| Mar 2025 | ₹448 Cr |
| Mar 2026 | ₹551 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Linde India Ltd trades at ₹6,742 as of 2026-11-19 with a market cap of ₹57,499 Cr. The company commands a premium valuation at a P/E of 116.22x and P/B of 13.1x, carries near-zero debt (debt-to-equity of 0.02), and has delivered a 10-year compounded profit growth of 41%, though recent performance shows a TTM profit decline of 2% and 3-year sales CAGR of -7%.
- Virtually debt-free balance sheet with a debt-to-equity ratio of just 0.02, providing significant financial flexibility and resilience through economic cycles
- Exceptional long-term profit compounding at 41% CAGR over the past 10 years, reflecting strong structural earnings growth
- 5-year stock price CAGR of 22% and 10-year CAGR of 34%, demonstrating sustained long-term wealth creation for shareholders
- Return on equity has improved from a 10-year average of 11% to 14% in the last year, indicating improving capital efficiency
- ROCE stands at 16.3%, comfortably above the cost of debt, showing productive deployment of total capital
- TTM revenue growth has rebounded to 13% after a 3-year sales CAGR of -7%, suggesting a potential sales recovery underway
- Consistent dividend payout of 21.8%, reflecting a disciplined capital allocation policy and commitment to returning cash to shareholders
- The stock is trading roughly 16% below its 52-week high of ₹8,049, having recovered well from its 52-week low of ₹5,544
- TTM P/E of 116.22x is extremely elevated, implying the stock prices in many years of future growth and leaves little room for earnings disappointment
- P/B ratio of 13.1x is very high, meaning investors are paying a significant premium over the company's book value per share
- 3-year compounded sales growth is negative at -7%, indicating a sustained period of revenue contraction in the recent past
- TTM profit growth has turned negative at -2%, showing earnings have begun to decline despite the sales recovery
- 3-year compounded profit growth has slowed sharply to just 1% versus the 10-year CAGR of 41%, suggesting the high-growth phase may be fading
- ROE of 12.87% is modest relative to the premium valuation, with the 3-year average ROE at only 13%
- Potential capitalisation of interest costs could be flattering reported profitability and understating true operating expenses
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Linde India is growing its top line at a healthy 12% clip and actively expanding via the Airtech acquisition, but profitability is under significant pressure with EBITDA margins compressing 1,200 basis points and net profit falling 31%. The market's positive reaction to weak Q2 results hints at forward-looking optimism, but margin recovery from rising operational costs remains the key risk to watch in coming quarters.
- EBITDA margin drops 1200 bps Nov 03
EBITDA declined 18% YoY to ₹232 crore in Q2, with margins contracting sharply from 44% to 32% due to soaring operational costs.
- Q2 net profit falls 31% Nov 03
Net profit dropped 30.5% YoY to ₹119 crore in Q2 from ₹171 crore, as higher revenue failed to offset rising operational expenses.
- Airtech acquisition for ₹111 crore Nov 13
Linde India acquired 100% of Airtech Cryogenic Gases for ₹111.20 crore to expand its industrial and medical gas operations.
- Q2 revenue grows 12% YoY Nov 03
Revenue rose 12.3% YoY to ₹723 crore from ₹644 crore in Q2, showing continued top-line momentum despite margin pressure.
- Stock resilient post weak Q2 Nov 03
Shares closed at ₹5,838, up 1.33% (₹76.65) on results day, suggesting investor confidence despite the profit decline.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 711 | 706 | 630 | 653 | 634 | 606 | 592 | 571 | 644 | 701 | 614 | 694 | 723 |
| Expenses | 538 | 520 | 452 | 469 | 456 | 414 | 382 | 374 | 362 | 444 | 441 | 494 | 492 |
| Operating Profit | 174 | 186 | 179 | 184 | 179 | 192 | 210 | 197 | 282 | 257 | 173 | 201 | 232 |
| OPM % | 24% | 26% | 28% | 28% | 28% | 32% | 35% | 34% | 44% | 37% | 28% | 29% | 32% |
| Other Income | 19 | 22 | 18 | 19 | 16 | 19 | 13 | 4 | 4 | 53 | 6 | 6 | 6.87 |
| Interest | 1 | 1 | 4 | 2 | 2 | 2 | 7 | 3 | 3 | 6 | 3 | 6 | 15.81 |
| Depreciation | 50 | 51 | 52 | 51 | 52 | 55 | 56 | 56 | 56 | 62 | 61 | 62 | 67.45 |
| PBT | 141 | 156 | 141 | 150 | 141 | 155 | 161 | 142 | 226 | 243 | 115 | 138 | 155 |
| Tax % | 24% | 25% | 26% | 25% | 26% | 26% | 27% | 26% | 25% | 21% | 26% | 25% | 26% |
| Net Profit | 107 | 117 | 104 | 112 | 104 | 114 | 118 | 105 | 169 | 192 | 85 | 103 | 115 |
| EPS (₹) | 12.51 | 13.74 | 12.23 | 13.08 | 12.24 | 13.37 | 13.82 | 12.32 | 19.82 | 22.46 | 9.99 | 12.08 | 13.48 |
| YoY Sales growth | 4 | 1 | 0 | −9 | −11 | −14 | −6 | −13 | 2 | 16 | 4 | 22 | 12 |
Profit & Loss
₹ Cr| Particulars | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 15m | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,491 | 1,567 | 1,825 | 2,033 | 2,192 | 1,762 | 1,471 | 2,112 | 3,136 | 2,769 | 2,485 | 2,531 | 2,733 |
| Expenses | 1,214 | 1,337 | 1,539 | 1,705 | 1,866 | 1,347 | 1,096 | 1,564 | 2,371 | 2,066 | 1,720 | 1,622 | 1,871 |
| Operating Profit | 277 | 230 | 287 | 328 | 326 | 415 | 375 | 548 | 765 | 702 | 765 | 909 | 862 |
| OPM % | 19% | 15% | 16% | 16% | 15% | 24% | 25% | 26% | 24% | 25% | 31% | 36% | 32% |
| Other Income | 11 | 22 | 34 | 11 | 23 | 862 | 32.64 | 348 | 109 | 77 | 68 | 67 | 72 |
| Interest | 103 | 90 | 116 | 116 | 103 | 86 | 6 | 3 | 6 | 7 | 13 | 14 | 30 |
| Depreciation | 181 | 162 | 195 | 206 | 199 | 177 | 176 | 181 | 253 | 201 | 214 | 235 | 252 |
| Exceptional Items | — | — | — | — | — | — | 11.15 | — | — | — | — | — | — |
| PBT | 4 | 1 | 10 | 16 | 47 | 1,013 | 236 | 711 | 614 | 571 | 606 | 727 | 652 |
| Tax % | −51% | −4164% | −31% | −17% | 29% | 28% | 34% | 28% | 13% | 25% | 26% | 24% | — |
| Net Profit | 5 | 23 | 13 | 19 | 33 | 727 | 156 | 514 | 536 | 426 | 448 | 551 | 495 |
| EPS (₹) | 0.63 | 2.75 | 1.57 | 2.22 | 3.93 | 85.27 | 18.24 | 60.26 | 62.82 | 49.99 | 52.51 | 64.59 | 58.01 |
| Div. Payout % | 237% | 27% | 48% | 45% | 38% | 12% | 16% | 22% | 19% | 24% | 23% | 19% | — |
| Sales growth | 4 | 5 | 17 | 11 | 8 | −20 | −16 | 44 | 48 | −12 | −10 | 2 | 13 |
Balance Sheet
₹ Cr| Particulars | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 |
| Reserves | 1,304 | 1,307 | 1,310 | 1,322 | 1,342 | 2,052 | 2,118 | 2,606 | 3,029 | 3,349 | 3,694 | 4,142 | 4,259 |
| Borrowings | 1,564 | 1,388 | 1,445 | 1,282 | 1,199 | 108 | 7 | 24 | 22 | 21 | 42 | 79 | 1,026 |
| Other Liabilities | 926 | 883 | 722 | 680 | 759 | 970 | 1,048 | 1,287 | 1,246 | 1,324 | 1,289 | 1,463 | 1,352 |
| Total Liabilities | 3,880 | 3,664 | 3,563 | 3,369 | 3,385 | 3,215 | 3,259 | 4,003 | 4,382 | 4,780 | 5,110 | 5,769 | 6,722 |
| Fixed Assets | 2,201 | 2,158 | 2,573 | 2,498 | 2,162 | 2,035 | 1,989 | 1,869 | 1,762 | 1,822 | 1,925 | 2,093 | 3,553 |
| CWIP | 356 | 577 | 80 | 36 | 44 | 53 | 17 | 68 | 225 | 483 | 975 | 1,343 | 1,091 |
| Investments | 15 | 15 | 15 | 15 | 0 | 0 | 2 | 2 | 16 | 27 | 42 | 43 | 55 |
| Other Assets | 1,308 | 915 | 895 | 821 | 1,179 | 1,127 | 1,251 | 2,064 | 2,378 | 2,448 | 2,168 | 2,291 | 2,023 |
| Total Assets | 3,880 | 3,664 | 3,563 | 3,369 | 3,385 | 3,215 | 3,259 | 4,003 | 4,382 | 4,780 | 5,110 | 5,769 | 6,722 |
Cash Flow
₹ Cr| Particulars | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 271 | 242 | 293 | 252 | 376 | 327 | 339 | 589 | 629 | 437 | 584 | 786 |
| Investing | −264 | −58 | −128 | −59 | −73 | 981 | −54 | 98 | −306 | −539 | −1,305 | −705 |
| Financing | −8 | −222 | −80 | −261 | −216 | −1,193 | −201 | −28 | −119 | −105 | −112 | −116 |
| Net Cash Flow | −1 | −37 | 85 | −68 | 87 | 115 | 84 | 659 | 203 | −208 | −833 | −35 |
| Free Cash Flow | 5 | 181 | 160 | 184 | 286 | 251 | 271 | 454 | 280 | −127 | −739 | 25 |
| CFO/EBITDA | 106 | 101 | 104 | 79 | 118 | 82 | 98 | 121 | 107 | 84 | 101 | 109 |
Ratios
| Particulars | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 78 | 71 | 63 | 61 | 79 | 101 | 73 | 47 | 63 | 57 | 73 |
| Inventory Days | 153 | 141 | 102 | 91 | 66 | 57 | 72 | 37 | 22 | 32 | 69 | 79 |
| Days Payable | 541 | 466 | 447 | 348 | 293 | 327 | 477 | 312 | 156 | 235 | 349 | 370 |
| Cash Conversion Cycle | −313 | −247 | −274 | −194 | −166 | −190 | −303 | −202 | −87 | −139 | −224 | −217 |
| Working Capital Days | −81 | 16 | −70 | −69 | −81 | −22 | 6 | −3 | −9 | −11 | −29 | −40 |
| ROCE % | 3% | 3% | 4% | 5% | 6% | 11% | 10% | 17% | 21% | 17% | 17% | 18% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Linde insights
65 extracted metrics across FY03–FY27.
Documents
- 3 Nov 2021
- 27 Aug 2020
- 5 Feb 2020
- 12 Feb 2019
- 29 Jan 2019
Frequently Asked Questions about Linde India
What does Linde India Ltd do?
Where is Linde India Ltd (LINDEINDIA) listed?
Which sector does Linde India Ltd belong to?
What is the market capitalisation of Linde India Ltd?
What is the PE ratio of Linde India Ltd?
What is the 52-week high and low of Linde India Ltd?
Does Linde India Ltd pay dividends?
What is the Return on Equity (ROE) of Linde India Ltd?
Company Information
Linde India Limited, a subsidiary of BOC Group,UK (owns 75% stake in the co), is primarily engaged in manufacture of industrial and medical gases and construction of cryogenic and non cryogenic air separation plants.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/LINDEINDIA.md for Linde India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.